SBC Medical to Announce Q4 and Full-Year 2025 Financial Results
SBC Medical Group (SBC) is now covered by BTIG Research. They set a "buy" rating and a $8.00 price target on the stock.
SBC Medical Appoints Sheng-FU Hsiao as CTO Leveraging Medical Big Data from 283 Global Locations and 6.63 Million Annual Patient Visits to Build a Scalable, AI-Driven Medical Management Infrastructure
SBC Medical-Supported Medical Corporation Nasukai Forms Strategic Alliance with Daibi Medical Aesthetics
SBC Medical-Supported Medical Corporation Nasukai Forms Strategic Alliance with Daibi Medical Aesthetics